Search results
Results from the WOW.Com Content Network
Drug-induced liver injury (DILI) is a cause of acute and chronic liver disease caused specifically by medications and the most common reason for a drug to be withdrawn from the market after approval. The liver plays a central role in transforming and clearing chemicals and is susceptible to the toxicity from these agents.
The Common Terminology Criteria for Adverse Events (CTCAE), [1] formerly called the Common Toxicity Criteria (CTC or NCI-CTC), are a set of criteria for the standardized classification of adverse events of drugs and treatment used in cancer therapy. The CTCAE system is a product of the US National Cancer Institute (NCI).
An ingredient in "A.P.C." tablet; withdrawn because of risk of cancer and kidney disease [42] Germany Denmark, UK, US, others Reason: nephropathy. [3] Phenformin and Buformin: 1977 France, Germany US Severe lactic acidosis [3] Phenolphthalein: 1997 US Possible carcinogen. [43] Phenoxypropazine: 1966 UK Hepatotoxicity, drug intereaction. [3 ...
The trials found the drug to be toxic with limited efficacy. For example, a Phase I study in 1984 evaluating 33 advanced cancer patients using a five-day continuous infusion schedule found hyperglycemia, hepatotoxicity, and thrombocytopenia as common toxicities with only one patient's cancer improving. [4]
These medications may also cause renal failure or certain kidney lesions, like those in the glomeruli or tubules. [32] Certain chemotherapy medications might cause hepatotoxic side effects in addition to renal toxicity, which calls for a thorough evaluation of liver function before starting treatment and possible dose adjustments. [33]
According to the study, more than 200 cases of acute liver injury have been linked to an ingredient common in what's generally regarded as a super healthy beverage—but it may not be as dire as ...
And, while there are anecdotal accounts of GLP-1s negatively impacting personality, there isn’t much research confirming it yet. Dr. Kumar and Dr. Russo believe that it’s possible, though.
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. More and more treatment options are becoming available for obesity and overweight. This includes type 2 diabetes drugs and weight ...